The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2022

Filed:

Oct. 02, 2017
Applicant:

Duke University, Durham, NC (US);

Inventors:

Darell D. Bigner, Mebane, NC (US);

Vidyalakshmi Chandramohan, Durham, NC (US);

Matthias Gromeier, Durham, NC (US);

Assignee:

Duke University, Durham, NC (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); C07K 16/28 (2006.01); G01N 33/58 (2006.01); G01N 33/60 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57484 (2013.01); C07K 16/2896 (2013.01); G01N 33/582 (2013.01); G01N 33/60 (2013.01); C07K 2317/20 (2013.01); C07K 2317/34 (2013.01); G01N 2333/70596 (2013.01); G01N 2333/908 (2013.01);
Abstract

A reliable assay to specifically detect CD155 in tissue sections has widespread use because CD155 is expressed widely among tumor types. Additionally, detected expression of CD 155 in glioblastoma cells is at levels commensurate with susceptibility to PVSRIPO (a poliovirus construct) infection and killing. An anti-CD155 antibody can achieve mono-specific detection of CD155 in immunoblots of tumor homogenates and immunohistochemistry of tumor formalin fixed, paraffin embedded sections. The assay can be used to determine appropriate use of PVSRIPO in oncolytic immunotherapy against cancers.


Find Patent Forward Citations

Loading…